コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 SOCS knocked down cells also displayed decreased parasit
2 SOCS performs its mapping within the context of 'color s
3 SOCS proteins can define host susceptibility to infectio
4 SOCS proteins regulate cytokine signals that control the
5 SOCS proteins, especially SOCS1 and SOCS3, are expressed
6 SOCS secretion into lung lining fluid was diminished by
7 SOCS, therefore, are essential controllers of macrophage
8 SOCS-1 and SOCS-3 transcriptional activity is induced by
9 SOCS-1 inhibits both type I and type II IFN activities b
10 SOCS-1 is a critical regulator of multiple signaling pat
11 SOCS-3 and SOCS-4 appear to play regulatory roles in a n
12 SOCS-3 deficiency in myeloid cells also promotes a highe
13 SOCS-3 expression was assessed in human cholangiocarcino
14 SOCS-3 gene induction by cAMP-elevating agents or the pr
15 SOCS-3 over-expression and SOCS-4 knockdown mutant lines
16 SOCS-3/IL-4 receptor complexes, however, were increased
17 SOCS-4 knockdown significantly reduced HaCaT migration a
18 SOCS-mediated insulin resistance and neuroprotection in
19 SOCS-mediated insulin resistance, as indicated by its in
24 D-1) and suppressor of cytokine signaling-1 (SOCS-1), the aim of this study was to examine their role
25 f Stat3, suppressor of cytokine signaling-1 (SOCS-1), was reduced in the brain metastatic melanoma ce
26 hy subjects or the THP-1 cell line for PD-1, SOCS-1, and IL-12 expression following HCV core treatmen
28 ssion of suppressor of cytokine signaling 3 (SOCS-3), a downstream target, are inhibited by CK2 small
29 IRAK-M), suppressor of cytokine signaling 3 (SOCS-3), and activating transcription factor 3 (ATF-3),
31 entified Suppressor of Cytokine Signaling-3 (SOCS-3) as a gene that exhibits greatly increased transc
32 ction of suppressor of cytokine signaling-3 (SOCS-3), a negative regulator of IL-6 receptor signaling
33 recruitment and activation of STAT1; and 3) SOCS-1, which normally terminates IFN-gamma-signaling, w
34 ing the formation of the Elongin BC/Cullin 5/SOCS (EC5S(mLANA)) complex and mLANA's E3 ligase activit
35 usion between a GFP-targeting nanobody and a SOCS-box containing ubiquitin ligase adaptor to target G
41 )-associated osteoclastogenesis, we analyzed SOCS expression profiles in CD4(+) T cells and the effec
42 CV core protein displayed increased PD-1 and SOCS-1 expression and decreased IL-12 expression, an eff
45 /M(Phi)s triggers the expression of PD-1 and SOCS-1, which can associate to deliver negative signalin
46 kinase inhibitory region of both SOCS-1 and SOCS-3 and blocks their inhibitory effects on the IFN-ga
47 ulatory cytokine IFN-beta induces SOCS-1 and SOCS-3 expression in primary astrocytes at the transcrip
48 inhibition of IFN-beta-inducible SOCS-1 and SOCS-3 in astrocytes enhances their proinflammatory resp
49 ts indicate that IFN-beta induces SOCS-1 and SOCS-3 in primary astrocytes to attenuate its own chemok
52 cs of 4 TSGs (p15(INK4B), CDH-1, DAPK-1, and SOCS-1) were studied in sequential bone marrow samples f
56 aims to explore the importance of SOCS-3 and SOCS-4 in regulating cellular traits associated with wou
60 ole in the coordinated regulation of CIS and SOCS expression in epithelial cells in response to C. pa
64 itin ligases, members of the Cbl, Hakai, and SOCS-Cul5-RING ligase families, stimulate the ubiquitina
65 equence variations in the ankyrin repeat and SOCS box containing gene 10 (ASB10) were recently associ
66 t identified the gene for ankyrin repeat and SOCS box protein 4 (ASB4) as the most highly differentia
68 t and find that gustavus, the B30.2/SPRY and SOCS box domain gene, contributes to this phenomenon.
69 anced suboptimal IFN-gamma activity, blocked SOCS-1-induced inhibition of STAT3 phosphorylation in IL
70 C/EBPbeta and -delta isoforms abolished both SOCS-3 induction and inhibition of IL-6 signaling in res
71 inds to the kinase inhibitory region of both SOCS-1 and SOCS-3 and blocks their inhibitory effects on
78 n with miR-155 and miR-146b mimics decreased SOCS-1 levels, increased MyD88 expression, and restored
82 results suggest that L. donovani may exploit SOCS for subverting macrophage apoptotic machinery towar
85 or healthy human volunteers was analyzed for SOCS expression by RNase protection assay and RT-PCR.
86 ombined inactivation of the genes coding for SOCS-3 and PTP-1B in brain cells, examined their sensiti
88 inical trial data from the U.S. NHLBI-funded SOCS trial and validated using data from the NHLBI SLIC
90 ased circulating IL-6 with increased hepatic SOCS-3 following LPS, suggesting SOCS-3 inhibited insuli
93 e developed mechanisms to induce robust host SOCS protein expression following infection, essentially
100 and STAT-3 activation play critical roles in SOCS-3 expression, which provides for feedback attenuati
101 results in BIC/miR-155 inhibition, increased SOCS-1 expression, and severely impaired tTreg cell deve
102 leptin and insulin action and that increased SOCS may mediate insulin and leptin resistance in obesit
104 al labile zinc pools which lead to increased SOCS-3 production through G-coupled receptor activation
105 STAT-1alpha is required for IFN-beta-induced SOCS-1 expression, while STAT-3 small interfering RNA st
109 e immunomodulatory cytokine IFN-beta induces SOCS-1 and SOCS-3 expression in primary astrocytes at th
110 These results indicate that IFN-beta induces SOCS-1 and SOCS-3 in primary astrocytes to attenuate its
111 rfering RNA inhibition of IFN-beta-inducible SOCS-1 and SOCS-3 in astrocytes enhances their proinflam
112 s was demonstrated in P. gingivalis-infected SOCS-3-knockout mice as compared with P. gingivalis-infe
113 STAT1-alpha phosphorylation, SOCS1-KIR, like SOCS-1, did not inhibit JAK2 autophosphorylation but inh
117 We show that specific mutations in the mLANA SOCS box (V199A, V199A/L202A, or P203A/P206A) disrupted
118 HV-4 recombinant viruses bearing these mLANA SOCS box mutations exhibited a deficit in latency amplif
120 gest that the JAK2 V617F has overcome normal SOCS regulation by hyperphosphorylating SOCS3, rendering
126 have developed a small peptide antagonist of SOCS-1 that corresponds to the activation loop of JAK2.
127 have developed a small peptide antagonist of SOCS-1, pJAK2(1001-1013), that had both an antiviral eff
132 and examine whether persistent elevation of SOCS levels in retina by chronic inflammation or cellula
133 insight into how dysregulated expression of SOCS increases IL-4 responses in allergic monocytes, and
135 r, were shown to down regulate expression of SOCS-1, a gene frequently silenced in MM that plays a cr
138 mouse model of T2D, macrophage expression of SOCS-3 is increased, and impaired IL-4-dependent IRS-2/P
141 rent study aims to explore the importance of SOCS-3 and SOCS-4 in regulating cellular traits associat
147 ip and a peptide corresponding to the KIR of SOCS-1, ((53))DTHFRTFRSHSDYRRI((68)) (SOCS1-KIR), both b
148 y with the kinase inhibitory region (KIR) of SOCS-1 for JAK2 recognition, inhibition of kinase activi
150 om sleep-deprived mice have higher levels of SOCS genes expression, lower migration capacity in vitro
153 ctively, these data suggest that the loss of SOCS-1 expression is a critical event, leading to elevat
156 istent with these observations, the mRNAs of SOCS family genes encoding the STAT signalling inhibitor
157 esponding to the kinase-inhibitory region of SOCS-1, SOCS1-KIR, similarly interacts with the activati
158 this study to investigate the regulation of SOCS proteins involved in intracellular signaling pathwa
159 dicating a novel role for TLR8 regulation of SOCS-1 function, whereas selective small interfering RNA
161 of epithelial cells to direct AM release of SOCS-containing vesicles in response to inflammatory ins
164 r that a better understanding of the role of SOCS proteins in viral diseases will be essential in our
166 se results show that the biological roles of SOCS-3 and PTP-1B do not fully overlap and that targetin
171 utations in the highly conserved HCCH and/or SOCS box motifs, which are required for assembly of a fu
174 vate the genes encoding ASB2 (ankyrin-repeat SOCS box containing protein 2) and SKP2 (S-phase kinase-
175 tivity of E proteins, whereas ankyrin-repeat SOCS box-containing protein 2 facilitates E protein ubiq
176 ed that expression of Id2 and ankyrin-repeat SOCS box-containing protein 2 was elevated in MZ B cells
177 been integrated with the previously reported SOCS alignment tool, and was used to align CpG methylati
178 Consistent with their intracellular roles, SOCS proteins have never been identified in the extracel
179 creases in suppressor of cytokine secretion (SOCS) 3 and suppressor of cytokine secretion 7, which ne
181 /cytokines/suppressor of cytokine signaling (SOCS) (spleen/heart), and production of nitric oxide (NO
183 ression of suppressor of cytokine signaling (SOCS) 1 in HSCs, and we demonstrate that SOCS1 expressio
184 ression of suppressor of cytokine signaling (SOCS) 1 in tissues from asthmatic patients and its possi
185 y inducing suppressor of cytokine signaling (SOCS) 2-dependent ubiquitinylation and proteasome-mediat
187 t role for suppressor of cytokine signaling (SOCS) 3 in IL-17 enhancement of IL-6 signaling in astroc
188 on of A20, suppressor of cytokine signaling (SOCS) 3, B-cell CLL/lymphoma (BCL) 3, TNF receptor-assoc
191 ression of Suppressor of Cytokine Signaling (SOCS) domain-containing viral proteins and cellular BC-b
192 ng to the suppressors of cytokine signaling (SOCS) family have been shown to regulate cytokine signal
193 ng several suppressor of cytokine signaling (SOCS) family members as well as MAPK pathway-regulating
195 ber of the suppressor of cytokine signaling (SOCS) family, is induced by TCR stimulation in CD8(+) T
197 known as suppressors of cytokine signaling (SOCS) have emerged as frequent targets of viral exploita
198 he role of suppressor of cytokine signaling (SOCS) molecules in periodontal immunity and RANKL-mediat
206 overy, the suppressor of cytokine signaling (SOCS) proteins have been studied for their potential use
211 er how the suppressor of cytokine signaling (SOCS) proteins regulate the quality and quantity of STAT
212 otein and suppressors of cytokine signaling (SOCS) proteins represents an important element of host c
215 led by the suppressor of cytokine signaling (SOCS) proteins, a family of proteins that negatively reg
216 s, namely, suppressor of cytokine signaling (SOCS) proteins, phosphatases, and protein inhibitor of a
218 nuated by suppressors of cytokine signaling (SOCS), a family of proteins consisting of eight members,
220 restingly, suppressor of cytokine signaling (SOCS)-1 directly associated with TLR8, but not with TLR7
224 e (COX)-2, suppressor of cytokine signaling (SOCS)-3, and matrix metalloproteinase (MMP)-9, no change
225 ot for the suppressor of cytokine signaling (SOCS)-box-containing ankyrin repeat proteins (ASB1-18),
226 regulator suppressor of cytokine signaling (SOCS)1 expression in immune (CD4T, CD8T, natural-killer
229 y STAT5 is suppressor of cytokine signaling (SOCS)1-a surprising finding for a known tumor suppressor
231 ression of suppressor of cytokine signaling (SOCS)3, a major negative feedback regulator of STAT3-act
232 show that Suppressor of Cytokine Signaling (SOCS)3, a molecular inhibitor of IFN signaling, may allo
233 leting the suppressor of cytokine signaling (SOCS)3, a negative regulator of gp130-mediated STAT3 act
234 ulation of suppressor of cytokine signaling (SOCS-3) proteins that are associated with hypothalamic l
237 rs of the suppressor of cytokine signalling (SOCS) family have been implicated in the regulation of a
238 or of the suppressor of cytokine signalling (SOCS) genes, which inhibit HSC migration and homing.
239 im-2, and Suppressor of Cytokine Signalling (SOCS)-1 resulted in partial restoration of v-Abl transfo
241 tion studies, and blocking PD-1 or silencing SOCS-1 in M/M(Phi) led to activation of STAT-1 during TL
243 ss was induced in 16-wk-old myeloid-specific SOCS-3-knockout and wild-type (WT) C57Bl6-B.129 mice by
245 sed hepatic SOCS-3 following LPS, suggesting SOCS-3 inhibited insulin signaling which produced the hy
247 f viral E3 ligase activity through targeting SOCS box motifs is a putative strategy to control gammah
256 roglial activation in vitro, suggesting that SOCS-3 may exert beneficial effects for immune-mediated
261 antiviral effect and synergism with IFN, the SOCS antagonist also exhibits adjuvant effects on humora
262 single nucleotide polymorphism (SNP) in the SOCS-1 gene (SOCS1+1125G > C; rs33932899) were found to
264 udy to determine if genetic variation in the SOCS-1 locus correlates with altered levels of IgE.
267 families of endogenous STAT inhibitors, the SOCS and PIAS families, to potentially inform the develo
269 ow report that genes encoding members of the SOCS (suppressor of cytokine signaling) family are criti
275 of cytokine signaling 6) is a member of the SOCS family of E3 ubiquitin ligases that can regulate re
276 the cell-specific activity of members of the SOCS family, which negatively regulate STAT function.
277 C57BL/6 mice to determine the ability of the SOCS-1 mimetics to protect mice against lethal vaccinia
278 NP increased transcriptional activity of the SOCS-1 promoter in reporter assays and human B cells.
281 The minimal, ERK-responsive element of the SOCS-3 promoter was localized to a region spanning nucle
284 the acetylation of histones H3 and H4 on the SOCS-3 promoter and the recruitment of STAT-3, c-Jun, c-
287 positions the ankyrin domain coaxial to the SOCS box-Elongin B/C complex and perpendicular to other
289 sophila Elongin B/C and Cullin-5 act via the SOCS-box of SOCS36E to reduce pathway activity specifica
291 protein-tyrosine phosphatases, thioredoxin, SOCS, and Egr1 in L. donovani-infected macrophages was f
293 ant-negative mutants greatly diminishes this SOCS-3 transcriptional increase in F9 Rex1(-/-) cells.
295 tion and transcellular delivery of vesicular SOCS proteins thus represent a new model for the control
299 tion, simulated outcomes agreed closely with SOCS trial outcomes, with treatment failure hazard ratio
300 lectively, we report that TLR8 coupling with SOCS-1 inhibits TLR7-mediated antiviral immunity during
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。